These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37656214)

  • 1. Protein N-glycosylation in the bronchoalveolar space differs between never-smokers and long-term smokers with and without COPD.
    Venkatakrishnan V; Thomsson KA; Padra M; Andersson A; Brundin B; Christenson K; Bylund J; Karlsson NG; Lindén A; Lindén SK
    Glycobiology; 2023 Dec; 33(12):1128-1138. PubMed ID: 37656214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased MUC1 plus a larger quantity and complex size for MUC5AC in the peripheral airway lumen of long-term tobacco smokers.
    Padra M; Andersson A; Levänen B; Premaratne P; Asgeirsdottir H; Tengvall S; Christenson K; Stockfelt M; Bozinovski S; Yoshihara S; Lantz AS; Palmberg L; Dahlén B; Larsson K; Qvarfordt I; Lindén SK; Lindén A
    Clin Sci (Lond); 2020 May; 134(10):1107-1125. PubMed ID: 32400877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased CD11b and Decreased CD62L in Blood and Airway Neutrophils from Long-Term Smokers with and without COPD.
    Stockfelt M; Christenson K; Andersson A; Björkman L; Padra M; Brundin B; Ganguly K; Asgeirsdottir H; Lindén S; Qvarfordt I; Bylund J; Lindén A
    J Innate Immun; 2020; 12(6):480-489. PubMed ID: 32829330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose Homeostasis in Relation to Neutrophil Mobilization in Smokers with COPD.
    Pournaras N; Andersson A; Kovach MA; Padra M; Che KF; Brundin B; Yoshihara S; Bozinovski S; Lindén SK; Jansson PA; Sköld MC; Qvarfordt I; Lindén A
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1179-1194. PubMed ID: 35620349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular cadmium in the bronchoalveolar space of long-term tobacco smokers with and without COPD and its association with inflammation.
    Sundblad BM; Ji J; Levänen B; Midander K; Julander A; Larsson K; Palmberg L; Lindén A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1005-13. PubMed ID: 27274222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD.
    Babusyte A; Stravinskaite K; Jeroch J; Lötvall J; Sakalauskas R; Sitkauskiene B
    Respir Res; 2007 Nov; 8(1):81. PubMed ID: 18001475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease.
    Moré JM; Voelker DR; Silveira LJ; Edwards MG; Chan ED; Bowler RP
    BMC Pulm Med; 2010 Oct; 10():53. PubMed ID: 20973980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression patterns associated with progression of chronic obstructive pulmonary disease in bronchoalveolar lavage of smokers.
    Plymoth A; Löfdahl CG; Ekberg-Jansson A; Dahlbäck M; Broberg P; Foster M; Fehniger TE; Marko-Varga G
    Clin Chem; 2007 Apr; 53(4):636-44. PubMed ID: 17303691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
    Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
    Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term smoking alters abundance of over half of the proteome in bronchoalveolar lavage cell in smokers with normal spirometry, with effects on molecular pathways associated with COPD.
    Yang M; Kohler M; Heyder T; Forsslund H; Garberg HK; Karimi R; Grunewald J; Berven FS; Magnus Sköld C; Wheelock ÅM
    Respir Res; 2018 Mar; 19(1):40. PubMed ID: 29514648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD.
    Holz O; Waschki B; Roepcke S; Watz H; Lauer G; Faulenbach C; Hohlfeld JM
    BMC Pulm Med; 2014 Mar; 14():30. PubMed ID: 24581181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-glycosylation patterns of plasma proteins and immunoglobulin G in chronic obstructive pulmonary disease.
    Pavić T; Dilber D; Kifer D; Selak N; Keser T; Ljubičić Đ; Vukić Dugac A; Lauc G; Rumora L; Gornik O
    J Transl Med; 2018 Nov; 16(1):323. PubMed ID: 30463578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower PDL1, PDL2, and AXL Expression on Lung Myeloid Cells Suggests Inflammatory Bias in Smoking and Chronic Obstructive Pulmonary Disease.
    Vasudevan S; Vásquez JJ; Chen W; Aguilar-Rodriguez B; Niemi EC; Zeng S; Tamaki W; Nakamura MC; Arjomandi M
    Am J Respir Cell Mol Biol; 2020 Dec; 63(6):780-793. PubMed ID: 32915645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased airway granzyme b and perforin in current and ex-smoking COPD subjects.
    Hodge S; Hodge G; Nairn J; Holmes M; Reynolds PN
    COPD; 2006 Dec; 3(4):179-87. PubMed ID: 17361498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and airway inflammation in severe exacerbations of COPD.
    Drost EM; Skwarski KM; Sauleda J; Soler N; Roca J; Agusti A; MacNee W
    Thorax; 2005 Apr; 60(4):293-300. PubMed ID: 15790984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Galectin-3 in Smokers with Chronic Obstructive Pulmonary Disease and Chronic Bronchitis: The Impact of Exacerbations.
    Sundqvist M; Andelid K; Ekberg-Jansson A; Bylund J; Karlsson-Bengtsson A; Lindén A
    Int J Chron Obstruct Pulmon Dis; 2021; 16():367-377. PubMed ID: 33642857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.
    Kunz LI; Lapperre TS; Snoeck-Stroband JB; Budulac SE; Timens W; van Wijngaarden S; Schrumpf JA; Rabe KF; Postma DS; Sterk PJ; Hiemstra PS;
    Respir Res; 2011 Mar; 12(1):34. PubMed ID: 21426578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD.
    Wen Y; Reid DW; Zhang D; Ward C; Wood-Baker R; Walters EH
    Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():327-34. PubMed ID: 21037956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease.
    Ito E; Oka R; Ishii T; Korekane H; Kurimoto A; Kizuka Y; Kitazume S; Ariki S; Takahashi M; Kuroki Y; Kida K; Taniguchi N
    J Proteomics; 2015 Sep; 127(Pt B):386-94. PubMed ID: 26206179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in the T-cell profiles of the airways in COPD patients associated with clinical phenotypes.
    Forsslund H; Yang M; Mikko M; Karimi R; Nyrén S; Engvall B; Grunewald J; Merikallio H; Kaarteenaho R; Wahlström J; Wheelock ÅM; Sköld CM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():35-48. PubMed ID: 28053515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.